Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04580589 · ClinicalTrials.gov registry record
DOAC ADRs Retrospective Study on Genetic Variations
A clinical trial of Drug-Related Side Effects and Adverse Reactions and Treatment Failure, sponsored by Cipherome.
- Completed
- Registry status
- 210
- Enrollment target
- 1
- Study location
NCT04580589 is a study of Drug-Related Side Effects and Adverse Reactions and Treatment Failure that has completed, run by Cipherome. The registered enrollment target is 210 participants, roughly in line with the 211-participant average among 4 other Drug-Related Side Effects and Adverse Reactions trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04580589, a study of Drug-Related Side Effects and Adverse Reactions and Treatment Failure, has completed, sponsored by Cipherome.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if the participant's genetic profile and clinical factors (age, drug dose, etc.) affect drug outcomes (i.e. serious bleeding) that the participant may have experienced since taking the drug (direct oral anticoagulant) for preventing blood clots from forming in the blood vessels.
Conditions Studied
Study Locations (1)
California
- Santa Clara Valley Medical Center - Santa Clara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2022-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04580589
The ClinicalTrials.gov registry entry for NCT04580589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 211-participant average among 4 other Drug-Related Side Effects and Adverse Reactions trials with a reported enrollment target. The listed sponsor is Cipherome, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Drug-Related Side Effects and Adverse Reactions appearing as the primary indexed condition, and to 0 interventions.
NCT04580589 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04580589 about?
NCT04580589 is a clinical study titled "DOAC ADRs Retrospective Study on Genetic Variations". The purpose of this study is to see if the participant's genetic profile and clinical factors (age, drug dose, etc.) affect drug outcomes (i.e. serious bleeding) that the participant may have experienced since taking the drug (direct oral anticoagulant) for preventing blood clots from forming in the...
What is the current status of trial NCT04580589?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2021-02-01. Estimated completion is 2022-10-31.
What conditions does trial NCT04580589 study?
This clinical trial studies the following conditions: Drug-Related Side Effects and Adverse Reactions, Treatment Failure.
Who is sponsoring clinical trial NCT04580589?
This trial is sponsored by Cipherome, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04580589 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug-Related Side Effects and Adverse Reactions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
RECRUITING · Phase 2
-
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
ACTIVE NOT RECRUITING
-
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
ACTIVE NOT RECRUITING
-
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
COMPLETED · NA
Explore more on PlainTrial
Drug-Related Side Effects and Adverse Reactions
All registered trials for this condition
Treatment Failure
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.